These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24850234)

  • 1. Chondroitin 6-Sulfate as a Novel Biomarker for Mucopolysaccharidosis IVA and VII.
    Shimada T; Tomatsu S; Yasuda E; Mason RW; Mackenzie WG; Shibata Y; Kubaski F; Giugliani R; Yamaguchi S; Suzuki Y; Orii K; Orii T
    JIMD Rep; 2014; 16():15-24. PubMed ID: 24850234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels.
    Dũng VC; Tomatsu S; Montaño AM; Gottesman G; Bober MB; Mackenzie W; Maeda M; Mitchell GA; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):129-38. PubMed ID: 23876334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry.
    Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; de Carvalho TG; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Kida K; Kubota M; Barrera L; Orii T
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S35-42. PubMed ID: 20107903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.
    Peracha H; Sawamoto K; Averill L; Kecskemethy H; Theroux M; Thacker M; Nagao K; Pizarro C; Mackenzie W; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Fukao T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):18-37. PubMed ID: 29779902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Di-sulfated Keratan Sulfate as a Novel Biomarker for Mucopolysaccharidosis II, IVA, and IVB.
    Shimada T; Tomatsu S; Mason RW; Yasuda E; Mackenzie WG; Hossain J; Shibata Y; Montaño AM; Kubaski F; Giugliani R; Yamaguchi S; Suzuki Y; Orii KE; Fukao T; Orii T
    JIMD Rep; 2015; 21():1-13. PubMed ID: 25712379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of liquid chromatography-tandem mass spectrometry and sandwich ELISA for determination of keratan sulfate in plasma and urine.
    Hintze JP; Tomatsu S; Fujii T; Montaño AM; Yamaguchi S; Suzuki Y; Fukushi M; Ishimaru T; Orii T
    Biomark Insights; 2011; 6():69-78. PubMed ID: 21792275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening and diagnosis of mucopolysaccharidoses.
    Tomatsu S; Fujii T; Fukushi M; Oguma T; Shimada T; Maeda M; Kida K; Shibata Y; Futatsumori H; Montaño AM; Mason RW; Yamaguchi S; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):42-53. PubMed ID: 23860310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.
    Hendriksz CJ; Harmatz P; Beck M; Jones S; Wood T; Lachman R; Gravance CG; Orii T; Tomatsu S
    Mol Genet Metab; 2013; 110(1-2):54-64. PubMed ID: 23665161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
    Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII.
    Rowan DJ; Tomatsu S; Grubb JH; Montaño AM; Sly WS
    J Inherit Metab Dis; 2013 Mar; 36(2):235-46. PubMed ID: 22971960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone Growth Induction in Mucopolysaccharidosis IVA Mouse.
    Rintz E; Herreño-Pachón AM; Celik B; Nidhi F; Khan S; Benincore-Flórez E; Tomatsu S
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of Elevated Concentrations of Urine Keratan Sulfate by UPLC-MSMS in Lysosomal Storage Disorders (LSDs): Comparison of Urine Keratan Sulfate Levels in MPS IVA Versus Other LSDs.
    Ellsworth KA; Pollard LM; Cathey S; Wood T
    JIMD Rep; 2017; 34():11-18. PubMed ID: 27469132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment.
    Tomatsu S; Montaño AM; Oikawa H; Smith M; Barrera L; Chinen Y; Thacker MM; Mackenzie WG; Suzuki Y; Orii T
    Curr Pharm Biotechnol; 2011 Jun; 12(6):931-45. PubMed ID: 21506915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characterisation of pulmonary function in patients with mucopolysaccharidoses IVA: A longitudinal analysis.
    Kenth JJ; Thompson G; Fullwood C; Wilkinson S; Jones S; Bruce IA
    Mol Genet Metab Rep; 2019 Sep; 20():100487. PubMed ID: 31341787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucopolysaccharidosis IVA and glycosaminoglycans.
    Khan S; Alméciga-Díaz CJ; Sawamoto K; Mackenzie WG; Theroux MC; Pizarro C; Mason RW; Orii T; Tomatsu S
    Mol Genet Metab; 2017; 120(1-2):78-95. PubMed ID: 27979613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of disease-specific chondroitin sulfate nonreducing end accumulation in mucopolysaccharidosis IVA.
    Lawrence R; Prill H; Vachali PP; Adintori EG; de Hart G; Wang RY; Burton BK; Pasquali M; Crawford BE
    Glycobiology; 2020 Jul; 30(7):433-445. PubMed ID: 31897472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chondroitin sulfate disaccharide is a specific and sensitive biomarker for mucopolysaccharidosis type IVA.
    Chin SJ; Saville JT; McDermott BK; Zankl A; Fletcher JM; Fuller M
    JIMD Rep; 2020 Sep; 55(1):68-74. PubMed ID: 32905071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of glycosaminoglycans in the amniotic fluid of a fetus with mucopolysaccharidosis VII.
    Kubaski F; Brusius-Facchin AC; Mason RW; Patel P; Burin MG; Michelin-Tirelli K; Kessler RG; Bender F; Leistner-Segal S; Moreno CA; Cavalcanti DP; Giugliani R; Tomatsu S
    Prenat Diagn; 2017 May; 37(5):435-439. PubMed ID: 28207930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
    Zhang H; Wood T; Young SP; Millington DS
    Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.